Showing 1 - 11 results of 11 for search 'M. Yu. Fedyanin', query time: 0.02s
Refine Results
-
1
Heterogeneity and clonal evolution of colorectal cancer by M. Yu. Fedyanin, H. H.-M. Elsnukaeva, S. A. Tjulandin
Published 2017-04-01Get full text
Article -
2
Prospects of therapeutic action on FGFR signaling pathway by M. Yu. Fedyanin, D. N. Khmelkova, T. S. Serebriyskaya, T. A. Nikolskaya, S. A. Tyulyandin
Published 2015-06-01Get full text
Article -
3
-
4
Nivolumab in real-life clinical practice by M. A. Lyadova, O. A. Pardabekova, R. R. Shakirov, V. K. Lyadov, M. Yu. Fedyanin
Published 2019-12-01Get full text
Article -
5
PROGNOSTIC FACTORS IN THE TREATMENT OF LUNG METASTASES FROM COLORECTAL CANCER by B. B. Akhmedov, M. M. Davydov, M. Yu. Fedyanin, V. A. Aliev, S. S. Gordeev, I. A. Dadyev
Published 2018-05-01Get full text
Article -
6
OVARIAN DYSGERMINOMAS: TREATMENT EXPERIENCE OF THE N.N.BLOKHIN CRC RAMS by O. N. Streltzova, M. Yu. Fedyanin, A. A. Tryakin, A. A. Bulanov, V. V. Zhordania, S. A. Tyulandin
Published 2014-09-01Get full text
Article -
7
Toxicity Associated with Immune Checkpoint Inhibitors: Analysis of Immune-Related Adverse Events with a Pembrolizumab Biosimilar (Pembroria) by M. Yu. Fedyanin, A. V. Snegovoy, V. V. Breder, Yu. N. Linkova, A. V. Zinkina-Orikhan, S. B. Setkina, S. N. Fogt, V. S. Chistiakov, N. A. Kravtsova
Published 2023-06-01Get full text
Article -
8
-
9
The prognostic value of circulating in blood tumor DNA as a marker of minimal residual disease in stage I–III colorectal cancer by E. M. Polyanskaya, M. Yu. Fedyanin, U. A. Boyarskikh, A. A. Kechin, E. A. Moroz, E. A. Khrapov, I. P. Oskorobin, D. V. Shamovskaya, V. A. Aliev, Z. Z. Mammadli, A. A. Tryakin, M. L. Filipenko, S. A. Tyulendin
Published 2022-06-01Get full text
Article -
10
Validation of high-throughput sequencing-based test system for detection of microsatellite instability in colorectal cancer samples by A. A. Lebedeva, A. N. Taraskina, A. I. Kavun, E. V. Belova, T. V. Grigor'eva, O. A. Kuznetsova, D. A. Kravchuk, L. D. Belyaeva, V. E. Nikulin, E. D. Khomenko, V. A. Mileyko, A. A. Tryakin, M. Yu. Fedyanin, M. V. Ivanov
Published 2025-04-01Get full text
Article -
11
Prognostic model integrating histology, systemic inflammation, and recurrence status predicts immunotherapy response in advanced non-small-cell lung cancer patients by F. V. Moiseenko, M. A. Krasavina, I. R. Agranov, E. V. Artemieva, A. P. Oganesian, A. S. Gabina, M. L. Makarkina, E. O. Elsakova, V. A. Henshtein, N. M. Volkov, V. V. Egorenkov, V. M. Moiseenko, M. Yu. Fedyanin, G. S. Kopeina, B. Zhivotovsky, A. V. Zamaraev
Published 2025-07-01Get full text
Article